> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FTC Charges Deceptive Claims for Prevagen Supplement
- URL: https://www.fdaweb.com/ftc-charges-deceptive-claims-for-prevagen-supplement/
- Published: 2017-01-10T12:00:00.000Z
- Updated: 2026-09-14T21:59:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137678

The Federal Trade Commission and the New York State attorney general have filed claims in a New York federal court charging the marketers of the dietary supplement Prevagen with making false and unsubstantiated claims that the product improves memory, provides cognitive benefits, and is “clinically shown” to work. FTC says that a national advertising campaign for the supplement included TV spots on national broadcast and cable networks and used charts depicting rapid and dramatic improvement in memory for product users. “In fact,” the complaint says, “the marketers relied on a study that failed to show that Prevagen works better than a placebo on any measure of cognitive function.”

The agencies say the firm’s marketing claims violate the FTC act and New York state laws. The complaint names several corporate defendants doing business as Sugar River Supplements and Quincy Bioscience Manufacturing and their co-founders, **Michael Bearman** and **Mark Underwood**, who appeared in infomercials for the product.